(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

INCRUSE ELLIPTA: Inhalation powder (62.5mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

UMECLIDINIUM (ue MEK li DIN ee um) is a bronchodilator. It helps open up the airways of your lungs. It is for chronic obstructive pulmonary disease (COPD), including chronic bronchitis or emphysema. Do NOT use for asthma or an acute asthma attack. Do NOT use for a COPD attack.

In-Depth Information

INCRUSE ELLIPTA 62.5mcg/actuation Powder for Inhalation (Institutional Package)

NDC: 001730873
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Emphysema, Chronic Obstructive Pulmonary Disease (COPD)

Storage Information
Store in a dry place
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Avoid direct heat and sunlight
Product should always be stored in the blister and only removed immediately before use
INCRUSE ELLIPTA 62.5mcg/actuation Powder for Inhalation (Institutional Package)

Reported Side Effects for INCRUSE ELLIPTA 62.5mcg/actuation Powder for Inhalation (Institutional Package)

Dry Mouth Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Bruise Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-8.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with INCRUSE ELLIPTA

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.